Clinical Therapeutics

Editorial comment
pp. 586-586(1)
Author: Krosnick A.

Safety profile of over-the-counter naproxen sodium
pp. 587-601(15)
Authors: DeArmond B.; Francisco C.A.; Lin J.-S.; Huang F.-Y.; Halladay S.; Bartizek R.D.; Skare K.L.

Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee
pp. 602-612(11)
Authors: Schnitzer T.J.; Ballard I.M.; Constantine G.; McDonald P.

A double-blind, multicenter comparative study of two regimens of clindamycin hydrochloride in the treatment of patients with acute streptococcal tonsillitis/pharyngitis
pp. 613-621(9)
Authors: Gallegos B.; Rios A.; Espidel A.; Reynal J.L.

Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1
pp. 622-636(15)
Authors: Sperber K.; Louie M.; Kraus T.; Proner J.; Sapira E.; Lin S.; Stecher V.; Mayer L.

Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis
pp. 637-647(11)
Authors: Brannan M.D.; Herron J.M.; Reidenberg P.; Affrime M.B.

Isradipine versus captopril in patients with essential hypertension
pp. 648-654(7)
Authors: Manolis A.J.; Gavras I.; Pieprzak M.; Gavras H.

Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: a double-blind, placebo-controlled study
pp. 656-666(11)
Authors: Dore R.; Ballard I.; Constantine G.; McDonald P.

Efficacy of long-term treatment with nipradilol, a nitroester-containing beta-blocker, in patients with mild-to-moderate essential hypertension
pp. 667-679(13)
Authors: Haneda T.; Ogawa Y.; Akaishi T.; Takeda H.; Tanazawa S.; Inoue H.; Ohki Y.; Kato J.; Morimoto H.; Kanaya K.; Onodera S.; Kikuchi K.

Patient responsiveness to calcitonin salmon nasal spray: a subanalysis of a 2-year study
pp. 680-685(6)
Authors: Overgaard K.; Lindsay R.; Christiansen C.

Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension
pp. 686-700(15)
Authors: Zidek W.; Spiecker C.; Knaup G.; Steindl L.; Breuer H.-W.M.; Hypertension Study Group

An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis
pp. 701-707(7)
Authors: Amin N.M.; Breadon G.

Efficacy and safety of mepyramine-theophylline-acetate in the treatment of asthmatic crisis in children
pp. 708-720(13)
Authors: Sienra-Monge J.J.; Rodriguez-Galvan Y.E.; Del Rio-Navarro B.E.; Berber A.

Lipoprotein(a) concentration in patients with chronic active hepatitis C before and after interferon treatment
pp. 721-728(8)
Authors: Malaguarnera M.; Giugno I.; Trovato B.A.; Panebianco M.P.; Siciliano R.; Ruello P.

Effects of long-term cilazapril treatment on glucose and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus
pp. 729-734(6)
Authors: Uchida K.; Kigoshi T.; Ishii T.; Kitazawa M.; Nakano S.; Morimoto S.

Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee
pp. 735-745(11)
Authors: Weaver A.; Rubin B.; Caldwell J.; McMahon F.G.; Lee D.; Makarowski W.; Offenberg H.; Sack M.; Sikes D.; Trapp R.; Rush S.; Kuss M.; Ganju J.; Bocanegra T.S.

Pharmaceutical economics & health policy - Editorial comment
pp. 748-748(1)
Author: Sclar D.A.

Two approaches to comparing hospital charges between cadaveric renal transplant patients who received Orthoclone OKT(R) 3 sterile solution or Atgam(R) sterile solution for induction therapy
pp. 749-769(21)
Authors: Schommer J.C.; Pleil A.M.; Pathak D.S.

Cost analysis of propofol versus thiopental induction anesthesia in outpatient laparoscopic gynecologic surgery
pp. 770-776(7)
Authors: Wagner B.K.J.; O'Hara D.A.

Translation and validation of the American Urological Association symptom index into Spanish
pp. 777-785(9)
Authors: Arocho R.; Kason N.M.; Colon B.; McMillan C.A.

Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications
pp. 786-790(5)
Author: Rascati K.

The pharmaceutical industry in Cuba
pp. 791-798(8)
Author: Tancer R.S.